medigraphic.com

2008, Number 2

<< Back Next >>

Anales de Radiología México 2008; 7 (2)

Caracterización fisicoquímica y clínica de los medios de contraste intravasculares iodados

Rodríguez NP, Dena EEJ, Basile LR, Fuentes GM, Fink JG, Marbez NE

Language: Spanish
References: 62
Page: 129-140
PDF size: 195.79 Kb.


ABSTRACT

Introduction: The use of intravascular non-ionic contrast media (gas, hydrosoluble or liposoluble substance) in the imaging area has proliferated in the last years due to its exceptional tolerance by the patients. The low osmolality of this type of contrast media contributes with benefits such as low increment of blood’s volume, low toxicity, and low effect upon the hemato encephalic barrier (bloodbrain).
Objective: The purpose of this article is to carry out a bibliographical revision on the characteristics, classification, physico-chemical properties, as well as the secondary effects (quimiotoxicity) of the intravascular non-ionic contrast medium.
Conclusions: A factor that interferes in the incidence of idiosyncratic or allergic reactions can be the patient’s psychological state. The previous treatment with antihistamine, corticosteroids or both has been accepted by some radiologists. Lopromide can be considered a universal agent for all the explorations and radiological procedures.


REFERENCES

  1. Dena EE, Rodríguez NP, Marbez NE, Rivera GH, Ramos SA, Ramírez AJL. Medios de contraste hidrosolubles y tratamiento de reacciones adversas. En: Dena EE, Rodríguez Nava P, Pérez Díaz MA (eds.). Manual de Técnicas en Radiología e Imagen. México: Editorial Trillas; 1998, p. 31-52.

  2. Thomsen HS. Introduction. Low Osmolar, Nonionic contrast agents in perspective. Supplement to Applied Radiology 2002; 7-8.

  3. Palmer FJ. The RACR survey of intravenous contrast media reactions. Final report. Low Osmolar, Nonionic contrast agents in perspective. Suplement to Applied Radiology 2002; 26-8.

  4. Dena EEJ, Rodríguez NP. Medios de contraste intravasculares yodados. En: Uriarte BV, Trejo FC (eds.). Farmacología Clínica. México: Editorial Trillas; 2003, p. 1108-14.

  5. Dena EJ, Rodríguez NP, Ramírez AJL, González de la Cruz J, Carrillo MMA. Medios de Contraste Intravasculares Iónicos vs No-Iónicos. Rev Mex Radiol 1993; 47: 113-7.

  6. Dena EJ, Rodríguez NP. Medios de contraste intravasculares en imagenología: pasado, presente y futuro. Primera parte (I). Rev Mex Radiol 1996; 50: 27-34.

  7. Dena EJ, Rodríguez NP. Medios de contraste intravasculares en imagenología: pasado, presente y futuro. Segunda parte (II). Rev Mex Radiol 1996; 50: 27-34.

  8. Poellinger A, et al. Magnetic resonance coronary angiography: Experimental Results with a Monomer-stabilized, Very Small Superparamagnetic Iron Oxide Particle (VSOP) Blood Pool Contrast Medium. 87th Scientific Assembly and Annual Meeting. RSNA, November 25-30, 2001, p. 518.

  9. Cardiovascular Imaging. Hope surrounds research on MR blood pool agents. Diagnostic Imaging America 2000.

  10. Welmers A, et al. Three-dimensional visualization in staging and diagnosis of urinary bladder cancer using high-resolution MRI. 87th Scientific Assembly and Annual Meeting. RSNA, November 25-30, 2001, p. 180.

  11. Ross PR. Resonancia Magnética del hígado. Actualidades. XXXVI Curso Anual de Radiologia e Imagen. Anal Radiol e Imagen 2002; 1:(1): 159-66.

  12. Sahani DV, Manfredi R, Saini S, Tanabe KK, Zukenberg L, Han PF. Preoperative evaluation of a new hepatobiliary contrast agent Gd-EOB-DTPA for liver lesion detection: Comparison with IOUS and pathology. MRI. 87th Scientific Assembly and Annual Meeting. RSNA, November 25-30, p. 518.

  13. Port M, Corot C, Raynal I, et al. Physicochemical and biological evaluation of P792, a new monogadolinated MRI blood-pool agent. Investigative Radiology 2001; 36(8): 445-54.

  14. Coosgrove DO, Blomley MJK. Section III Ultrasound agents. Echo-enhancing (Contrast) agents for ultrasound. In: Dawson P, Cosgrove DO, Grainger RG (eds.). Textbook of Contrast Media. Isis Medical Media Ltd.; 1999, p. 451-2.

  15. Levovist. Monografía. Schering Diagnóstico; 1997.

  16. Gramiak R. The Beginnings of ultrasound contrast. In: Goldberg BB (ed.). Ultrasound Contrast Agents. Mrtin Dunitz Ltd.; 1997, p. 1-8.

  17. Dena EE, Rodríguez NP, Tanus HJ, Ramos SO, Guardiola AF, Bezauri PR, Pérez-Mendizabal JA, Ponte RR. Principios físicos de ultrasonido y ecorrealzadores. En: Dena EE, Rodríguez NP, Pérez DMA (eds.). Manual de Técnicas en Radiología e Imagen. México: Editorial Trillas; 1998, p. 192-5.

  18. Speck U, Behrends-Steins, Blaszkiewicz P, et al. X-Ray Contrast Media. Over view, use and Pharmaceutical aspects. Srpinger-Verlag. Berlin: Heidelberg; 1991, p. 1-48.

  19. Mc Lennan BL, Stolberg HO. Intravascular Contrast Media. Ionic versus Nionionic, Current Status. Radiol Clin of North Am 1991; 29(3): 437-54.

  20. Bais HM, O’Farril CG, Negrete CR. Medios de Contraste Hidrosolubles. Rev Mex Radiol 1978; 32(2): 75-92.

  21. Mühlenkamp WB, Wagen Knecht J. Lo esencial sobre ULTRAVIST. Grunlegaen, Fortbilddungdo-Reihe, Nedizinizche, Schering. Kontrast Mittel; 1990, p. 3-90.

  22. Felix R, Fisher HW, Kormano M, et al. Contrast Media from the past to the future. Symposium Berlin, 1987. Fischer HW (ed.). Historical aspects of Contrast Media Development. Scheringed, Stuttgar: Thieme; 1987, p. 3-18.

  23. Mosqueira SR. Tabla periódica de los elementos. 41 reimpr. México: Editorial Patria; 1997.

  24. Krause W. Preclinical characterization of iopromide. Low Osmolar, Nonionic contrast agents in perspective. Supplement to Applied Radiology 2002; 10-23.

  25. Grainger RG. Intravascular Contrast Media. The past, the present and the future. Brit J Radiol 1982; 55(649): 1-18.

  26. Eloy R, Corot C, Belleville J. Contrast Media for Angiography, Physicochemical Properties, Physicochemical Properties. Pharmacokinetics and Biocompatibility. Clinical Materials 1991; 7: 89-197.

  27. Felix R, Fischer W, Kormano M, et al. Contrast Media from the past to the future. Symposium Berlin, 1987. In: Gringer RG (ed.). Osmolality and osmolality. Related side effects. Schering de. Stuttgart, NY: Thieme; 1987, p. 25-31.

  28. Grainger RG. Osmolality of intravascular radiological contrast media. Brit J Radiol 1980; 53(632): 739-46.

  29. Taenzar V, Zieitler E. Contrast media in urography, angiography and computerized tomography. Stuttgart: Thieme, NY; 1982.

  30. Mutzel W, Winmann J. Chemistry, Psychochemistry and Pharmacology of Know and contrast media for angiography. Urography and Enhacement 1983; 2-10.

  31. Mutzel W, Siefert HM, Speck U. Biochemical- Pharmacology Properties of Iohexol. Acta Radiol 1980; 362: 2-10.

  32. Mutzel W, Speck U. Hemodynamic Responses to Contrast Media. Invest Radiol 1970; 5: 424-35.

  33. Kozuka T, Uchida H, Nihon Schering KK. 6th Ed. (Zoeizai-Yoran) Osaka, Japan; 1988, p. 2-43.

  34. Weiseneski JA, Gerts EW, Dahigren M, Muslin A. Comparison of low osmolaty ionic (ioxaglato) versus nonionic (Iopamidol) contrast media in cardiac angiography. AJ Cardiol 1989; 63: 489-95.

  35. Missri J, Jeresaty RM. Ventricular fibrillation during coronary angiography. Reduce incidence with Nonionic contrast media. Catheterization and cardiovascular diagnosis 1990; 19: 4-7.

  36. Maccarini PR, Benenari PM, Bellinti G, Piscitelli G. Coronariografia sinitra con iopamidolo nell infarto miocardioco in fase precoce. Radiol Med 1988; 76: 28-32.

  37. Baudovy Y, Lasry JL, Lagneau P, Abassade PH, De Moulliac MV. Evaluation du risque ischemique miocardique et arithmogene des angiographies numerisees par voie veinuse. A pros d un essai comparatif de ioxaglate et de iopamidol. J Radiol 1988; 69(3): 211-6.

  38. Murdock CHJ, Davis MJE, Ireland MA, et al. Comparison of meglumine sodium diatrizoate, iopamidol and iohexol for coronary angiography and ventriculography. Catheterization and Cardiovascular Diagnosis 1990; 19: 179-83.

  39. Ballerini L, Barbaresi F, Binaghi, et al. Iopamidol in cardioangiographie: A retrospective, multicentre study. Part II. Pediatric Patients. IJ Cardiac Imaging 1992; 8: 45-52.

  40. Bashore TM, Davidson CHJ, Mark BD. Iopamidol use in the cardiac catheterization laboratory: a retrospective analysis of 3,313 patients. Cardio 1988; 5(3): 6-10.

  41. Hirsfiel JW, Wieland J, Davis CA, et al. Hemodynamic and electrocardiographyc effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate. Invest Radiol 1989; 24: 138-44.

  42. Saito H, Kimura K, Takayima M, et al. Comparison of ionic and nonionic low osmolar contrast media in coronary arteriography. A crossover study in children. Invest Radiol 1988; 24: 910-3.

  43. Brismar J, Jacobson BF, Jorulf H. Miscellaneous adverse effects of low-versus high-osmolality contrast media. A Study Revised. Radiology 1991; 179: 19-23.

  44. Dawson P. Non-ionic contrast agents and coagulation. Invest Radiol 1988; 23(2): 310-7.

  45. Stormorken H. Effects of the contrast media on the hemostatic and thrombotic mechanism. Invest Radiol 1988; 23(2): 318-25.

  46. Aspelin P, Schmidin-Schonbein H, Malota H. Do non-ionic contrast media increase red cell aggregation and clot formation? Invest Radiol 1988; 23(2): 326-33.

  47. Kimball JP, Sansone VJ, Diters LA, Wissel PS. Red blood cell aggregation versus blood clot formation in ionic and nonionic contrast media. Invest Radiol 1988; 23(2): 334-9.

  48. Zucker MB, Mauss EA. Erytrocyte aggregation in iohexol and other contrast media. Invest Radiol 1988; 23(2): 340-5.

  49. Abdes WA. Effects of contrast media on fibrinogen and factor VII. Invest Radiol 1988; 23(2): 346-50. Graboeski EF. Effects of contrast media on erytrocytes and platelet interactions with endotelial cell monolayers exposed to flowing blood. Invest Radiol 1988; 23(2): 351-8.

  50. Lang JH, Lasser EC. Binding of roentgenography contrast media to serum albumin. Invest Radiol 1967; 2: 396-400.

  51. Plez AM, Fox AJ, Vi-Uela F, Lylyk P. A comparison of iopamidol and iohexol in cerebral angiography. AJ Am Neuroradiol 1988; 9(6): 1163-6.

  52. Smaltino F, Gambardela A, Meoli S, Elefante R. Evaluation comparative de i’ceopamidol (b 1500) et de i’ iotalamate de methhylglucamine (conray 60%) en angiographie cerebrale. Wackenheim noionic contrast media, 1982, Interimages, Luxembur XV Cong. Radiol. Brussel. 24, 6, 1, 7, 81. 107-110, 1982.

  53. Biasizzo E, Lavaroni A, Fabres NG, et al. L angiographie numérique dans l étude des tumeurs cérébrales. Radiologique J Cepur 1991; 11: 23-33.

  54. Murzel W, Langer M, Keysser R. Renal excretion of iopramide and iopamidol after intravenous administration in digital substraction angiography. Recent developments in nonionic contrast media. Georg Thieme Verlag; 1989, p. 101-4.

  55. Loughran CF. Clinical intravenous urography, comparative trial of ioxaglate and iopamidol. Radiology 1986; 161: 455-8.

  56. Colombaro G, Caresano A, Del Favero C, et al. Urografía con mezzi di contrasto non ionic. Radiol Med 1988; 75: 61-4.

  57. Cochran ST, Ballar JW, Katzberg RW, et al. Evaluation of iopamidol and diatrizoate in excretory urography, and double blind clinical study. AJR 1988; 151: 523-7.

  58. Katayama H, Yamaguchi K, Takashima T, et al. Adverse reactions to contrast media. Ionic CM versus non-ionic CM. Radiology 1990; 175(3): 625.

  59. Mathias K, Seeman W. Clinical trials in adults. Radiol Med 1986; 72: 44-6.

  60. Longstaff AJ, Hensons JHL. Brochoespasm following intravenous injection of ionic and non-ionic low osmolality contrast media. Clin Radiol 1985; 36: 651-3.

  61. Hagen B. Systemische und lokale reaktionen bei der beinphlebographie unter besonderer berucksichtigung posthphlebographischer komplikationen. Radiol 1984; 24: 46-50.

  62. Palmer FJ. The RACR survey of intravenous contrast media, final report. Australasina Radiol 1988; 32(4): 426.




2020     |     www.medigraphic.com